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Résumé en
anglais
SummaryFibroMeters are blood tests for liver fibrosis with several specificities: two
main diagnostic targets (fibrosis stage and area of fibrosis); adaptation to specific
causes; and results confirmed by an expert system. Thus, FibroMeters comprise six
different tests: one for staging and one for quantitation of liver fibrosis in each of the
three main causes of chronic liver disease—chronic viral hepatitis, alcoholic liver
disease (ALD) and non-alcoholic fatty liver disease (NAFLD). FibroMeters display a
high overall diagnostic accuracy and are the only tests to correctly classify 100% of
HCV patients without fibrosis or with cirrhosis. They have 90% predictive values in a
higher proportion of patients than with other usual blood tests. A 90% correct
classification is available in 100% of HCV patients with the following reliable
diagnostic intervals: F0/1, F1/2, F2±1, F3±1. In real-life conditions, the
reproducibility of FibroMeters is higher than that of liver biopsy or ultrasonographic
elastometry. FibroMeters are robust tests with the most stable diagnostic
performance across different centers. Optional tests are also available, such as a
specific one for cirrhosis, which has a diagnostic accuracy of 93.0% (AUROC: 0.92)
and a 100% positive predictive value for diagnosis of HCV cirrhosis. Determination
by FibroMeters of the area of fibrosis – the only direct, non-invasive, quantitative
measurement of liver fibrosis – are especially useful for following-up cirrhosis as it
correlates well with clinical events. FibroMeters are also very accurate in HVB or
HIV-HCV co-infected patients. The tests specific for ALD and NAFLD also have a high
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